Furthermore, upregulated protein expression in the tumorous tissue was observed for the actors of the eIF2α-ATF4- CHOP pathway, as well as markers such as RACK1, PDIA6, and ERO1α, all of which have been proposed as potential therapeutic targets in HCC [17,20,40,41]. This evidence concerns the gene ERO1A and hepatocellular carcinoma.